This is an HTML version of an attachment to the Freedom of Information request 'DG SANTE contacts with industry re. Supplementary Protection Certificates (SPCs) manufacturing waiver'.




Ref. Ares(2018)6622688 - 21/12/2018
From:
SANTE PHARMACEUTICALS B5
Sent:
jeudi 5 avril 2018 11:47
To:
Cc:

 
Subject:
RE: The European Commission's work on the SPC legislation
Dear Ms 

 
Thank you for your email. 
 
We hereby acknowledge the receipt of your email and we would like to thank you for sharing the letter with us. 
 
Kind regards, 
 
Unit “Medicines: policy, authorisation and monitoring“ 
 
 
European Commission 
DG Health and Food Safety 
_____________ 
This message represents solely the views of its author and can not be regarded as the official position of the 
Commission. It is intended solely for the person to whom it is addressed and may contain confidential information. If 
you have received this message in error, please notify me as soon as possible.
 
 
 
From: 
  
Sent: Wednesday, April 4, 2018 9:28 AM 
To:
 
 
Subject: TR: The European Commission's work on the SPC legislation 
 
Dear Ms 
, dear 
, dear 
 and 

 
Please find attached a letter sent by the Secretary-General of EUCOPE to Secretary General Selmayr on the 
subject of the SPC legislation.  
 
Best regards,  
 
 
 
 
 
European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) 
 
Belgium 
 
Mob. 
 
Tel. 
 
www.eucope.org  
 
1

 
 
 
De : 
  
Envoyé : lundi 26 mars 2018 18:35 
À : 'xxxxxx.xxxxxxx@xx.xxxxxx.xx' <xxxxxx.xxxxxxx@xx.xxxxxx.xx> 
Cc : 'xxxxxxxxxxxxxxxxxxxxxxxx@xx.xxxxxx.xx' <xxxxxxxxxxxxxxxxxxxxxxxx@xx.xxxxxx.xx>; 
'xxxxxxxx.xxxxxxxxxx@xx.xxxxxx.xx' <xxxxxxxx.xxxxxxxxxx@xx.xxxxxx.xx>; 'jyrki-katainen-
xxxxxxx@xx.xxxxxx.xx' <xxxxxxxxxxxxxxxxxxxxxx@xx.xxxxxx.xx>; 'xxxxxxxxxxxxxxxxxxxxxxxx@xx.xxxxxx.xx' 
<xxxxxxxxxxxxxxxxxxxxxxxx@xx.xxxxxx.xx>; 'xxxxxxxxxxxxxxxxxxxxxxxxx@xx.xxxxxx.xx' <cecilia-
xxxxxxxxxxxxxxxxx@xx.xxxxxx.xx>; 
 
Objet : The European Commission's work on the SPC legislation 
 
Dear Secretary General Selmayr,  
 
Please let me congratulate you on your new role, and find attached our today’s letter in the above mentioned 
matter. We are looking forward to receiving your respective comments. 
 
Yours sincerely, 
 
 
    
 
European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) 

 
Belgium 
  
Tel. 
 
Fax. 
 
www.eucope.org 
 
 
 
2